ARDT

Ardent Health Partners, LLC

Fundamental data last updated:June 13, 2026

We may earn a commission from partner links. This content is for informational purposes only and is not financial advice. Information may be delayed or inaccurate.

company profile

SECTOR

Healthcare

industry

Medical - Care Facilities

Exchange

NYSE

County of HQ

US

Next Earnings Date

08/04/2026

Business Summary

Ardent Health Partners, LLC owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee. Ardent Health Partners, LLC is a subsidiary of EGI-AM Investments, L.L.C.

 


Analyze ARDT on TradingView

VALUATION

P/E

9.95

Market Cap ($M USD)

$1.36B

Forward P/E

6.95

PEG

0.16

PRICE TO SALES

0.21

PRICE TO BOOK

0.77

EV / EBITDA

3.91

5-Year Average P/E

Free Cash Flow Yield

15.77%

DCF Value

$45.60

Graham Number

$16.21

Price to FCF

6.34

EV to FCF

9.16

Earnings Yield

10.05%

FCF Yield

15.77%

DIVIDEND

Yield

0.00%

Annual Payout

$0.00

Payout Ratio

0.00%

Consecutive Years of Dividend Growth

5-Year Dividend Growth Rate

Financial Health & Profitability

Earnings Per Share

$0.95

Next Year EPS Growth Estimate

$1.36

Next Year Revenue Growth Estimate

$720.60B

Return on Equity (ROE)

9.08%

FREE CASH FLOW

Operating Margin

8.98%

Debt-to-Equity

1.34

Piotroski F-Score

5

Altman Z-Score

2.05

Return on Invested Capital (ROIC)

13.42%

Current Ratio

2.12

Quick Ratio

2.00

Net Debt to EBITDA

1.20

Interest Coverage

11.15

Gross Profit margin

49.72%

FCF PER SHARE

$1.51

REVENUE PER SHARE

$45.51

Analyze ARDT on TradingView

Gainseekers Quantitative Analysis

Summary

Ardent Health Partners, LLC appears to be a deep value opportunity, trading significantly below its DCF Value and Graham Number. The Forward P/E of 7.44 and an Earnings Yield of 9.40% suggest the market is underestimating its earnings potential. Despite a moderate Altman Z-score of 2.07, indicating some financial risk, the stock’s valuation metrics imply a mispricing. With a Price/Book ratio of 0.82, the market seems to be overlooking the company’s intrinsic value, presenting a compelling case for value investors.

AI Exposure / Tech Reliance

In the rapidly evolving healthcare sector, Ardent Health Partners is well-positioned to leverage AI and tech advancements. As a player in medical care facilities, integrating AI could enhance operational efficiencies and patient outcomes. This adaptability is crucial for maintaining competitiveness in a tech-driven future.

The Bull Case

For the discerning GARP investor, Ardent Health Partners offers a tantalizing proposition. With a robust ROIC of 13.42% and a healthy FCF Yield of 14.75%, the company demonstrates strong capital efficiency and cash generation. The Piotroski F-Score of 5 and an Operating Margin of 8.98% further underscore its operational strength. These metrics suggest a company with solid pricing power and effective management, making it an attractive buy.

The Bear Case

Despite its strengths, Ardent Health Partners faces notable challenges. The Price/Sales ratio of 0.23 and a Price/Book of 0.82 might seem appealing, but the company's lack of dividend yield and a zero payout ratio could deter income-focused investors. Furthermore, the stock's distance from its 52-week high by 53.12% indicates potential market skepticism. While debt levels are manageable, the company's growth story must overcome these structural hurdles to justify a bullish stance.

Market Sentiment & Smart Money

Short Interest %

Analyst Consensus

Buy

Average Analyst Price Target

$13.00

Institutional Ownership %

1-Year Beta

0.93

Insider Buying % (6 Mo)

Distance to 52-Week High

63.64%

Distance to 52-Week Low

14.69%

EARNINGS SURPRISE %

55.56%

50-DAY SMA

$9.43

200-DAY SMA

$10.62

⚠️ Financial Disclaimer:
This content is for informational purposes only and is not financial advice. Information may be delayed or inaccurate. We may earn a commission from partner links.